Great news from the European Congress on Obesity (ECO) in Malaga earlier this week: obesity drugs such as Wegovy and Mounjaro slash the chances of dying from a range of killer diseases including strokes, heart attacks and various cancers. Roughly speaking, they halve the risk. GLP-1s appear to “affect the biology of diseases of ageing”, […]
Kaerus Bioscience’s lead candidate KER-0193 granted Orphan Drug Designation and Rare Pediatric Drug Designation by U.S. FDA for treatment of Fragile X syndrome (FXS) Kaerus Bioscience announces that its lead candidate KER-0193 has been granted both Orphan Drug and Rare Pediatric Drug Designations for the treatment of Fragile X syndrome (FXS) by the U.S. Food […]
Alchemab Therapeutics signs landmark $415m licensing agreement for ATLX-1282 with Eli Lilly and Company Alchemab Therapeutics announced that it has entered into a $415m licensing agreement with Eli Lilly and Company for ATLX-1282, Alchemab’s first-in-class IND-ready programme for amyotrophic lateral sclerosis (ALS) and other neurodegenerative conditions. ATLX-1282 is the first programme out of Alchemab’s entirely […]
Cycuria Therapeutics launched with a distinguished advisory board and significant public grant funding Cycuria Therapeutics launched, announcing a distinguished Advisory Board and the successful approval of grant funding from two leading Austrian national funding organisations. Cycuria is developing a first-in-class, protein-based therapy with a differentiated dual-mechanism for hard-to-treat blood cancers, including acute myeloid leukaemia (AML). Novo […]
Here in Britain, as elsewhere in Europe, we are used to the price of eggs having risen since the Covid pandemic. It’s okay though, prices have stabilised and have even come down slightly. But in the US the high price of eggs – taken as emblematic of the country’s dissatisfaction with the Biden administration as […]
